158 related articles for article (PubMed ID: 37267601)
21. Long-Term Evolution of the Adaptive NKG2C
Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Alari-Pahissa E; Pérez-Sáez MJ; Altadill M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M
J Immunol; 2021 Oct; 207(7):1882-1890. PubMed ID: 34470855
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells.
Djaoud Z; Riou R; Gavlovsky PJ; Mehlal S; Bressollette C; Gérard N; Gagne K; Charreau B; Retière C
J Innate Immun; 2016; 8(4):374-85. PubMed ID: 27116381
[TBL] [Abstract][Full Text] [Related]
23. The Direct Influence of Cytomegalovirus Lysate on the Natural Killer Cell Receptor Repertoire.
Soleimanian S; Yaghobi R; Karimi MH; Geramizadeh B; Roozbeh J
Iran J Allergy Asthma Immunol; 2021 Dec; 20(6):721-733. PubMed ID: 34920655
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals.
Kristensen AB; Wragg KM; Vanderven HA; Lee WS; Silvers J; Kent HE; Grant MD; Kelleher AD; Juno JA; Kent SJ; Parsons MS
Clin Exp Immunol; 2022 Dec; 210(2):163-174. PubMed ID: 36053502
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus.
Ariyanto IA; Estiasari R; Edwar L; Makwana N; Lee S; Price P
Immunol Invest; 2019 May; 48(4):345-354. PubMed ID: 30422022
[TBL] [Abstract][Full Text] [Related]
26. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.
Hendricks DW; Balfour HH; Dunmire SK; Schmeling DO; Hogquist KA; Lanier LL
J Immunol; 2014 May; 192(10):4492-6. PubMed ID: 24740502
[TBL] [Abstract][Full Text] [Related]
27. NKG2C
Gondois-Rey F; Chéret A; Granjeaud S; Mallet F; Bidaut G; Lécuroux C; Ploquin M; Müller-Trutwin M; Rouzioux C; Avettand-Fenoël V; Moretta A; Pialoux G; Goujard C; Meyer L; Olive D
Clin Transl Immunology; 2017 Jul; 6(7):e150. PubMed ID: 28791125
[TBL] [Abstract][Full Text] [Related]
28. Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
Martínez-Rodríguez JE; Cobo-Calvo A; Villar LM; Munteis E; Blanco Y; Rasal R; Vera A; Muntasell A; Alvarez-Lafuente R; Saiz A; Alvarez-Cermeño JC; Martínez-Yélamos S; Roquer J; López-Botet M
Mult Scler; 2016 May; 22(6):741-52. PubMed ID: 26362897
[TBL] [Abstract][Full Text] [Related]
29. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
[TBL] [Abstract][Full Text] [Related]
30. Reduced expansion of CD94/NKG2C
Puiggros A; Blanco G; Muntasell A; Rodríguez-Rivera M; Nonell L; Altadill M; Puigdecanet E; Arnal M; Calvo X; Gimeno E; Abella E; Abrisqueta P; Bosch F; Yélamos J; Ferrer A; López-Botet M; Espinet B
Int J Lab Hematol; 2021 Oct; 43(5):1032-1040. PubMed ID: 33615729
[TBL] [Abstract][Full Text] [Related]
31. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.
Wu Z; Sinzger C; Frascaroli G; Reichel J; Bayer C; Wang L; Schirmbeck R; Mertens T
J Virol; 2013 Jul; 87(13):7717-25. PubMed ID: 23637420
[TBL] [Abstract][Full Text] [Related]
32. An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.
Muñoz-Cobo B; Giménez E; Solano C; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Navarro D
J Med Virol; 2014 May; 86(5):806-11. PubMed ID: 24105728
[TBL] [Abstract][Full Text] [Related]
33. Dynamic Changes in Natural Killer Cell Subset Frequencies in the Absence of Cytomegalovirus Infection.
Gyurova IE; Schlums H; Sucharew H; Ambroggio L; Ochayon DE; Win HT; Bryceson YT; Bernstein DI; Waggoner SN
Front Immunol; 2019; 10():2728. PubMed ID: 31824507
[TBL] [Abstract][Full Text] [Related]
34. Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections.
Malone DFG; Lunemann S; Hengst J; Ljunggren HG; Manns MP; Sandberg JK; Cornberg M; Wedemeyer H; Björkström NK
Front Immunol; 2017; 8():525. PubMed ID: 28533779
[TBL] [Abstract][Full Text] [Related]
35. NKG2C
Grutza R; Moskorz W; Senff T; Bäcker E; Lindemann M; Zimmermann A; Uhrberg M; Lang PA; Timm J; Cosmovici C
J Immunol; 2020 Jun; 204(11):2910-2917. PubMed ID: 32284334
[TBL] [Abstract][Full Text] [Related]
36. Perceived stress, cytomegalovirus titers, and late-differentiated T and NK cells: Between-, within-person associations in a longitudinal study of older adults.
Reed RG; Presnell SR; Al-Attar A; Lutz CT; Segerstrom SC
Brain Behav Immun; 2019 Aug; 80():266-274. PubMed ID: 30885843
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus Seropositivity is Associated with Airflow Limitation in a Cohort of Veterans with a High Prevalence of Smoking.
Burkes R; Osterburg A; Hwalek T; Lach L; Panos RJ; Borchers MT
Chronic Obstr Pulm Dis; 2021 Oct; 8(4):441-449. PubMed ID: 34329551
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
Comeau EM; Holder KA; Fudge NJ; Grant MD
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
[TBL] [Abstract][Full Text] [Related]
39. Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.
Redondo-Pachón D; Crespo M; Yélamos J; Muntasell A; Pérez-Sáez MJ; Pérez-Fernández S; Vila J; Vilches C; Pascual J; López-Botet M
J Immunol; 2017 Jan; 198(1):94-101. PubMed ID: 27913630
[TBL] [Abstract][Full Text] [Related]
40. Detailed phenotypic and functional characterization of CMV-associated adaptive NK cells in rhesus macaques.
Hasan MZ; Höltermann C; Petersen B; Schrod A; Mätz-Rensing K; Kaul A; Salinas G; Dressel R; Walter L
Front Immunol; 2022; 13():1028788. PubMed ID: 36518759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
